Paper26850595
MicroRNA-873 mediates multidrug resistance in ovarian cancer cells by targeting ABCB1.
Wu DD and 4 others. Tumour Biol, 2016. Cited by 60 papers, by iCite.
Cite this record
ConductScience Library. MicroRNA-873 mediates multidrug resistance in ovarian cancer cells by targeting ABCB1. Papers, record 26850595. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26850595
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics24
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cystadenocarcinoma | Major topic |
| MicroRNAs | Major topic |
| Neoplasm Proteins | Major topic |
| Ovarian Neoplasms | Major topic |
| RNA, Neoplasm | Major topic |
| 3' Untranslated Regions | |
| ATP Binding Cassette Transporter, Subfamily B | |
| Animals | |
| Antineoplastic Agents, Alkylating | |
| Antineoplastic Agents, Phytogenic | |
| Cell Line, Tumor | |
| Cisplatin | |
| Drug Resistance, Multiple | |
| Drug Resistance, Neoplasm | |
| Female | |
| Heterografts | |
| Humans | |
| Mice | |
| Mice, Nude | |
| Paclitaxel | |
| RNA, Antisense | |
| RNA, Messenger | |
| Random Allocation | |
| Transfection |
Source PubMed
References32
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8094074 | Distinct P-glycoprotein expression in two subclones simultaneously selected from a human colon carcinoma cell line by cis-diamminedichloroplatinum (II). | Int J Cancer | 1993 | https://conductscience.org/library/papers/8094074 | PubMed |
| 2 | 26182353 | Abraxane, the Nanoparticle Formulation of Paclitaxel Can Induce Drug Resistance by Up-Regulation of P-gp. | PLoS One | 2015 | https://conductscience.org/library/papers/26182353 | PubMed |
| 3 | 25311867 | miR-193a-3p regulates the multi-drug resistance of bladder cancer by targeting the LOXL4 gene and the oxidative stress pathway. | Mol Cancer | 2014 | https://conductscience.org/library/papers/25311867 | PubMed |
| 4 | 15694393 | Concentration-dependent collateral sensitivity of cisplatin-resistant gastric cancer cell sublines. | Biochem Biophys Res Commun | 2005 | https://conductscience.org/library/papers/15694393 | PubMed |
| 5 | 21070600 | Down-regulated miR-331-5p and miR-27a are associated with chemotherapy resistance and relapse in leukaemia. | J Cell Mol Med | 2011 | https://conductscience.org/library/papers/21070600 | PubMed |
| 6 | 23178914 | miR-137 restoration sensitizes multidrug-resistant MCF-7/ADM cells to anticancer agents by targeting YB-1. | Acta Biochim Biophys Sin (Shanghai) | 2013 | https://conductscience.org/library/papers/23178914 | PubMed |
| 7 | 26136956 | Avastin® in combination with gemcitabine and cisplatin significantly inhibits tumor angiogenesis and increases the survival rate of human A549 tumor-bearing mice. | Exp Ther Med | 2015 | https://conductscience.org/library/papers/26136956 | PubMed |
| 8 | 8106143 | Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines. | Cancer Res | 1993 | https://conductscience.org/library/papers/8106143 | PubMed |
| 9 | 23173671 | MicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinoma. | BMC Cancer | 2012 | https://conductscience.org/library/papers/23173671 | PubMed |
| 10 | 15930349 | Comparative preclinical and clinical pharmacokinetics of a cremophor-free, nanoparticle albumin-bound paclitaxel (ABI-007) and paclitaxel formulated in Cremophor (Taxol). | Clin Cancer Res | 2005 | https://conductscience.org/library/papers/15930349 | PubMed |
| 11 | 18668431 | Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition. | Xenobiotica | 2008 | https://conductscience.org/library/papers/18668431 | PubMed |
| 12 | 26055179 | Drug-Resistant Urothelial Cancer Cell Lines Display Diverse Sensitivity Profiles to Potential Second-Line Therapeutics. | Transl Oncol | 2015 | https://conductscience.org/library/papers/26055179 | PubMed |
| 13 | 26323558 | MiR-873 acts as a novel sensitizer of glioma cells to cisplatin by targeting Bcl-2. | Int J Oncol | 2015 | https://conductscience.org/library/papers/26323558 | PubMed |
| 14 | 25670861 | MicroRNA-873 (miRNA-873) inhibits glioblastoma tumorigenesis and metastasis by suppressing the expression of IGF2BP1. | J Biol Chem | 2015 | https://conductscience.org/library/papers/25670861 | PubMed |
| 15 | 23933187 | The anti-chemoresistant effect and mechanism of MUC1 aptamer-miR-29b chimera in ovarian cancer. | Gynecol Oncol | 2013 | https://conductscience.org/library/papers/23933187 | PubMed |
| 16 | 25909324 | MicroRNA let-7c Inhibits Cell Proliferation and Induces Cell Cycle Arrest by Targeting CDC25A in Human Hepatocellular Carcinoma. | PLoS One | 2015 | https://conductscience.org/library/papers/25909324 | PubMed |
| 17 | 21939554 | MicroRNA signature of cis-platin resistant vs. cis-platin sensitive ovarian cancer cell lines. | J Ovarian Res | 2011 | https://conductscience.org/library/papers/21939554 | PubMed |
| 18 | 24786846 | miRNAs for the detection of multidrug resistance: overview and perspectives. | Molecules | 2014 | https://conductscience.org/library/papers/24786846 | PubMed |
| 19 | 26396496 | MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs. | Drug Des Devel Ther | 2015 | https://conductscience.org/library/papers/26396496 | PubMed |
| 20 | 24645868 | MicroRNAs and their relevance to ABC transporters. | Br J Clin Pharmacol | 2014 | https://conductscience.org/library/papers/24645868 | PubMed |
Cited by41
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 60 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41964673 | The striking divergence of ABCB1 mRNA expression and P-glycoprotein protein levels in M1 and M2 macrophages associates with the microRNA miR-21-3p, a regulator of "RNA binding protein, mRNA processing factor". | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/41964673 | PubMed |
| 39808313 | MiRNAs: main players of cancer drug resistance target ABC transporters. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | https://conductscience.org/library/papers/39808313 | PubMed |
| 39185494 | MicroRNA‑mediated approaches in ovarian cancer therapy: A comprehensive systematic review. | Oncol Lett | 2024 | https://conductscience.org/library/papers/39185494 | PubMed |
| 39114709 | MiR-125b targeted regulation of MKNK2 inhibits multiple myeloma proliferation and invasion. | Am J Transl Res | 2024 | https://conductscience.org/library/papers/39114709 | PubMed |
| 38434767 | Novel players in the development of chemoresistance in ovarian cancer: ovarian cancer stem cells, non-coding RNA and nuclear receptors. | Cancer Drug Resist | 2024 | https://conductscience.org/library/papers/38434767 | PubMed |
| 36420446 | Nucleic acid vaccination strategies for ovarian cancer. | Front Bioeng Biotechnol | 2022 | https://conductscience.org/library/papers/36420446 | PubMed |
| 35620395 | The Emerging Roles and Therapeutic Implications of Epigenetic Modifications in Ovarian Cancer. | Front Endocrinol (Lausanne) | 2022 | https://conductscience.org/library/papers/35620395 | PubMed |
| 35582723 | Resistance to cis- and carboplatin initiated by epigenetic changes in ovarian cancer patients. | Cancer Drug Resist | 2019 | https://conductscience.org/library/papers/35582723 | PubMed |
| 35582590 | MicroRNAs and cancer drug resistance: over two thousand characters in search of a role. | Cancer Drug Resist | 2019 | https://conductscience.org/library/papers/35582590 | PubMed |
| 35326459 | MicroRNA as a Potential Therapeutic Molecule in Cancer. | Cells | 2022 | https://conductscience.org/library/papers/35326459 | PubMed |
| 34676171 | MiR-873-5p: A Potential Molecular Marker for Cancer Diagnosis and Prognosis. | Front Oncol | 2021 | https://conductscience.org/library/papers/34676171 | PubMed |
| 34593006 | MicroRNAs as the critical regulators of Cisplatin resistance in ovarian cancer cells. | J Ovarian Res | 2021 | https://conductscience.org/library/papers/34593006 | PubMed |
| 34512721 | The Emerging Role of Non-coding RNAs in Drug Resistance of Ovarian Cancer. | Front Genet | 2021 | https://conductscience.org/library/papers/34512721 | PubMed |
| 34046834 | MicroRNAs' role in the environment-related non-communicable diseases and link to multidrug resistance, regulation, or alteration. | Environ Sci Pollut Res Int | 2021 | https://conductscience.org/library/papers/34046834 | PubMed |
| 33802524 | Small Non-Coding-RNA in Gynecological Malignancies. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33802524 | PubMed |
| 33133224 | circFAT1(e2) Promotes Papillary Thyroid Cancer Proliferation, Migration, and Invasion via the miRNA-873/ZEB1 Axis. | Comput Math Methods Med | 2020 | https://conductscience.org/library/papers/33133224 | PubMed |
| 32555352 | The tumor-suppressive role of microRNA-873 in nasopharyngeal carcinoma correlates with downregulation of ZIC2 and inhibition of AKT signaling pathway. | Cancer Gene Ther | 2021 | https://conductscience.org/library/papers/32555352 | PubMed |
| 32099406 | miR-873-5p Inhibits Cell Migration and Invasion of Papillary Thyroid Cancer via Regulation of CXCL16. | Onco Targets Ther | 2020 | https://conductscience.org/library/papers/32099406 | PubMed |
| 32010295 | MicroRNA-873 serves a critical role in human cervical cancer proliferation and metastasis via regulating glioma-associated oncogene homolog 1. | Exp Ther Med | 2020 | https://conductscience.org/library/papers/32010295 | PubMed |
| 31936634 | Role of microRNAs as Clinical Cancer Biomarkers for Ovarian Cancer: A Short Overview. | Cells | 2020 | https://conductscience.org/library/papers/31936634 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ABCB1 | 5243 | PubTator's text mining | https://conductscience.org/library/genes/5243 | NCBI Gene |
| MIR873 | 100126316 | PubTator's text mining | https://conductscience.org/library/genes/100126316 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26850595
GET https://conductscience.org/api/papers/v1/26850595/references?page=2